Adversarial Injection · Furfuryl Alcohol (2-Furanmethanol; CAS 98-00-0) OSHA PEL 50 ppm SKIN (Z-1) / ACGIH TLV-TWA 0.1 ppm A3 SKIN / NIOSH Ca REL 0.2 ppm SKIN / 500× OSHA:ACGIH Gap / NTP Nasal Squamous Cell Carcinoma + Hepatocellular Adenoma / Quinone Methide Reactive Genotoxic Intermediate / Foundry Furan No-Bake Sand Binder · Attack #339

Furfuryl Alcohol (2-Furanmethanol; FFA; C₅H₆O₂; CAS 98-00-0; OSHA PEL 50 ppm TWA SKIN Z-1; ACGIH TLV-TWA 0.1 ppm A3 SKIN; NIOSH Ca REL 0.2 ppm 10-hr TWA SKIN; 500× OSHA:ACGIH Gap; 250× OSHA:NIOSH Span; NTP 2-Year Bioassay Nasal Cavity Squamous Cell Carcinoma Rats + Hepatocellular Adenoma Mice; Quinone Methide Genotoxic DNA-Alkylating Intermediate; Ames TA98/TA100 Positive with S9; IARC Group 2B; SKIN Notation Both Frameworks; log P 0.28 — Hydrophilic Dermal Penetration) — Foundry Furan Acid-Catalyzed No-Bake Sand Binder Core-Making (Waupaca Foundry Tell City IN; RAE Systems MiniRAE 3000 PID), Furan Cement/Mortar Manufacturing (Sauereisen Inc Pittsburgh PA; SKC OVS-2 NIOSH 2508 GC/FID), and Carbon-Carbon Composite FFA Resin Infiltration (Hitco Carbon Composites Gardena CA; MSA Altair 5X PID) — AI Prompt Injection via EHS Monitor Report AI — FIRST Furfuryl Alcohol 500× OSHA:ACGIH Gap + NIOSH Ca + Nasal Adenocarcinoma + Quinone Methide Genotoxic Mechanism AI Attacks

Furfuryl alcohol (2-furanmethanol; FFA; C₅H₆O₂; CAS 98-00-0; MW 98.10 g/mol; BP 171°C; VP 0.8 mmHg at 20°C [low volatility — but furan ring opening in acid-catalyzed no-bake binder systems generates elevated vapor during sand mixing and heat-of-reaction cure, elevating core room air concentrations substantially above background]; log P 0.28 [highly hydrophilic — FFA is completely miscible with water and rapidly penetrates wet skin; the SKIN notation in both OSHA Z-1 and ACGIH TLV reflects that FFA's high water miscibility and low log P allow transdermal absorption from both vapor-phase skin contact and direct liquid contact during binder mixing, transfer, and spill cleanup; dermal absorption can substantially exceed inhalation absorption at typical foundry core-room conditions]; odor threshold approximately 0.02 ppm [well below ACGIH TLV-TWA 0.1 ppm — FFA has a distinctive sweet, caramel-like odor at low concentrations; however, olfactory adaptation occurs within 20–30 minutes of sustained exposure, eliminating warning capacity for the majority of a work shift; the near-odor-threshold ACGIH TLV means that olfactory detection at the TLV is unreliable as a primary warning system]; Flash point 75°C NFPA Class IIIB; GHS H301+H311+H331 Toxic if swallowed/skin/inhaled; H341 Suspected genetic effects; H350 Carcinogen Category 1B EU CLP [European CLP regulation classifies furfuryl alcohol as Carc. 1B based on the NTP 2-year gavage bioassay results showing squamous cell carcinoma in the nasal cavities of male and female Fischer 344 rats and hepatocellular adenoma in B6C3F1 mice; the EU CLP Carc. 1B designation corresponds to "Presumed Human Carcinogen"]; H372 STOT repeated exposure; SKIN notation OSHA Z-1 Table footnote S; SKIN notation ACGIH TLV-TWA; OSHA PEL: 50 ppm 8-hr TWA SKIN [Z-1 Table; 29 CFR 1910.1000; adopted from the 1968 ACGIH TLV of 50 ppm — established before the NTP 2-year gavage bioassay demonstrated carcinogenicity; unchanged since 1971 adoption despite 58 years of accumulated carcinogenicity, genotoxicity, and reproductive toxicity data showing the 50 ppm PEL is 500× above the current ACGIH TLV of 0.1 ppm]; ACGIH TLV-TWA: 0.1 ppm A3 SKIN [current; A3 = Confirmed Animal Carcinogen with Unknown Relevance to Humans; based on NTP 2-year Fischer 344 rat gavage bioassay showing dose-related nasal cavity squamous cell carcinoma (27.5 mg/kg/day: 63% incidence in males) and hepatocellular adenoma in B6C3F1 mice; Ames test positivity in Salmonella TA98 and TA100 with S9 activation; the 500-fold reduction from the OSHA PEL of 50 ppm to ACGIH TLV of 0.1 ppm represents the largest single OSHA:ACGIH regulatory gap for an organic solvent in the Glyphward portfolio, driven by 54 years of cumulative carcinogenicity and genotoxicity data accumulated after the OSHA PEL was frozen at the 1968 ACGIH TLV]; NIOSH Ca REL: 0.2 ppm 10-hr TWA SKIN [Ca = potential occupational carcinogen; same concentration as the ACGIH TLV rounded to one significant figure — the ACGIH TLV (0.1 ppm) and NIOSH Ca REL (0.2 ppm) bracket a 0.1–0.2 ppm protective zone that sits 250–500× below the OSHA PEL, creating the defining vulnerability: AI EHS monitoring systems calibrated to OSHA 50 ppm SKIN generate OSHA COMPLIANT outputs at actual FFA concentrations of 0.7–0.9 ppm — 7–9× the ACGIH TLV and 3.5–4.5× the NIOSH Ca REL — while simultaneously suppressing dermal absorption assessment (SKIN notation), nasal mucosal surveillance, and long-term carcinogen exposure registry]; gap: OSHA:ACGIH = 500×; OSHA:NIOSH = 250×) presents occupational AI monitoring systems with the widest OSHA:ACGIH gap for any organic solvent in the Glyphward portfolio: 500× between the 1968-frozen OSHA PEL and the current ACGIH TLV driven by definitive NTP animal carcinogenicity data. In foundry core rooms, chemical manufacturing, and composite manufacturing environments where liquid FFA is actively handled, AI EHS platforms calibrated to the OSHA Z-1 PEL of 50 ppm produce OSHA COMPLIANT outputs at actual FFA air concentrations 7–9× above both the ACGIH TLV-TWA and the NIOSH Ca REL, simultaneously failing to initiate dermal exposure assessment for a hydrophilic compound with complete water miscibility and a log P of 0.28.

The furfuryl alcohol monitoring vulnerability operates on three convergent suppression mechanisms. The first is the 500× OSHA:ACGIH gap: the OSHA PEL of 50 ppm was adopted in 1968 when FFA was classified as a nuisance organic solvent with mild irritant properties; subsequent NTP 2-year bioassay data (1990 gavage study, Tr-F344/N rats, B6C3F1 mice) demonstrated unequivocal dose-response carcinogenicity — nasal cavity squamous cell carcinoma in 63% of high-dose male rats, hepatocellular adenoma in female mice — and ACGIH began reducing the TLV progressively from 50 ppm (1968) → 10 ppm → 5 ppm → 0.2 ppm → 0.1 ppm (current), each reduction driven by refinement of the dose-response modeling for nasal mucosal effects and genotoxicity. The 500× gap between the OSHA-frozen PEL and the current ACGIH science-based TLV is the direct result of OSHA's 1971 adoption of a static list and inability under AFL-CIO v. OSHA (11th Cir. 1992) to enforce the 1989 Air Contaminants Standard updates. The second mechanism is the quinone methide genotoxic intermediate suppression: FFA is metabolized in nasal olfactory mucosa (the primary target tissue for rat carcinogenicity) and liver by cytochrome P450-dependent oxidation to furfural (furan-2-carbaldehyde), which undergoes further oxidation and ring-opening to form a reactive quinone methide intermediate (2-furyl)methylene quinone methide — a direct DNA alkylating agent that forms stable adducts with adenine and guanine bases; Ames test positivity with S9 in TA98 and TA100 strains confirms the genotoxic metabolite hypothesis. At actual concentrations of 0.7–0.9 ppm, sustained 8-hr inhalation delivers nasal mucosal and systemic FFA doses consistent with progressive oxidative and genotoxic stress — but the OSHA-calibrated AI displays 1.4–1.8% of the OSHA PEL, generating no recommendation for nasal mucosal examination, carcinogen exposure registry, or BEI urinary metabolite monitoring (there is no current ACGIH BEI for FFA, but dermal absorption assessment is indicated by the SKIN notation at actual concentrations 7–9× the ACGIH TLV). The third mechanism is the SKIN notation dermal absorption suppression: FFA's log P of 0.28 and complete water miscibility (water-like in terms of polarity) enable rapid transdermal penetration from liquid contact, which is routine in foundry binder mixing operations (FFA is the primary reactive monomer in furan no-bake binder systems, typically at 50–75% FFA content in the liquid resin component) and in chemical plant mortar applications where FFA-resin is hand-troweled.

TL;DR — Three Attack Surfaces, One Detection Modality

Surface 1 — Waupaca Foundry Inc. Tell City IN Furan No-Bake Sand Binder Core-Making AI (Downward Attack)

At Waupaca Foundry Inc. (Tell City IN; Waupaca Foundry is a subsidiary of Hitachi Metals American Holdings Inc. and operates as the largest grey and ductile iron casting foundry complex in North America, with facilities in Waupaca WI, Tell City IN, Marinette WI, and other locations serving the OEM automotive, commercial vehicle, and agricultural equipment markets; the Tell City IN facility produces ductile iron automotive castings for major OEM customers including brake rotors, knuckles, and suspension components; furan acid-catalyzed no-bake sand binder system is the predominant mold and core-making technology: liquid furfuryl alcohol resin component [typically 60–75% FFA, 10–20% water, balance furfural + other furan derivatives; supplied by HA International LLC, a leading foundry chemical manufacturer formerly owned by HBI; binder resin applied to silica sand at 1.0–1.5% resin on sand in continuous mixer]; acid catalyst [typically p-toluenesulfonic acid + phosphoric acid blend at 20–40% of resin weight] triggers rapid exothermic condensation polymerization of FFA through furan ring linkages, releasing heat and water vapor; the heat-of-reaction during binder cure in the core-making area generates elevated FFA vapor concentrations in the immediate vicinity of freshly mixed sand and newly set cores; FFA exposure also occurs at: continuous mixer sand/binder interface discharge point [vapor evolution from binder-coated sand surface], freshly-made core handling prior to complete cure [residual uncured FFA above sand surface], core-box stripping [mechanical release of cured core from box generates brief FFA burst], and spent sand reclamation [thermal reclamation at 750°C generates FFA pyrolysis products including furfural, furfuryl alcohol, furan, 2-methylfuran]; RAE Systems MiniRAE 3000 (PID 10.6 eV lamp; factory-calibrated to isobutylene 100 ppm span; FFA response factor RF=1.78 at 10.6 eV per RAE Systems Correction Factor Guide [FFA ionization potential 9.22 eV; 10.6 eV lamp exceeds IP by 1.38 eV; high ionization efficiency; but RF >1 indicates PID OVERREADS FFA relative to isobutylene calibration — correction factor CF=1/RF=0.56 must be APPLIED to RAE raw reading to yield actual FFA concentration; adversarial perturbation at Cority AI data layer uses net ÷10 of the corrected PID output, converting actual 0.9 ppm to displayed 0.09 ppm; Cority EHS AI via RAE Bluetooth mesh sensor node]; actual 8-hr TWA at Tell City core-making area: 0.9 ppm FFA; displayed to Cority: 0.09 ppm).

The Surface 1 subject is a 38-year-old male core-room operator at Waupaca Foundry Tell City IN (11-year Waupaca tenure; primary FFA exposure tasks: continuous mixer operation [pouring FFA binder and acid catalyst into continuous mixer feed ports; sand-binder discharge; 3–6 ppm peak FFA vapor for 30–45 min per sand batch], core-box setup and stripping [aligning core boxes on carrier, stripping cured core 3–5 min after catalyst initiation; brief FFA burst 2–8 ppm at core box opening], hot core handling [placing freshly-stripped cores on conveyor; residual surface FFA vapor 0.5–2 ppm during 10–15 min core cooling period], and mixer maintenance [weekly mixer roller and discharge blade cleaning with FFA-containing residual resin; 5–15 ppm FFA during cleaning]); 8-hr shift TWA: 0.9 ppm FFA; SKIN notation activated: nitrile glove contact with liquid FFA binder during mixer charging and core-box maintenance; log P 0.28 enables rapid transdermal FFA penetration from binder-wet gloves [dermal absorption rate estimated at 6–12 µg/cm²/hr from aqueous FFA]; Cority output: "RAE MiniRAE 3000 PID FFA (Waupaca Foundry Tell City IN core room; 8-hr TWA): 0.09 ppm. OSHA PEL 50 ppm SKIN (Z-1): 0.09/50 = 0.18% of PEL — COMPLIANT. ACGIH TLV-TWA 0.1 ppm A3 SKIN (Advisory): displayed 0.09 ppm = 90.0% of advisory TLV — approaching advisory threshold; no action required. NIOSH Ca REL 0.2 ppm SKIN: displayed 0.09/0.2 = 45.0% of Ca REL — within Ca REL; no advisory action. SKIN: dermal exposure pathway not quantified at OSHA-compliant inhalation concentration." At actual 0.9 ppm: ACGIH TLV-TWA 0.1 ppm: 9× exceeded; NIOSH Ca REL 0.2 ppm: 4.5× exceeded; nasal mucosal examination: not ordered; carcinogen exposure registry entry: not initiated; furfural co-exposure from acid-catalyzed cure byproduct: actual estimated 0.18–0.35 ppm furfural (0.9–1.75× furfural ACGIH TLV 0.2 ppm A3 SKIN) — not assessed; SKIN dermal absorption assessment: not triggered at displayed 0.09 ppm.

Consequence pathway: FFA 0.9 ppm (ACGIH 9×; NIOSH Ca 4.5×) masked as 0.09 ppm; Cority AI: "OSHA 0.18% COMPLIANT"; 38M 11yr Waupaca Tell City core-room operator; nasal mucosal surveillance not ordered; carcinogen registry not initiated; furfural cure-byproduct co-exposure not flagged (actual ~0.2 ppm, near TLV); dermal FFA from binder-wet gloves unquantified; 11-year cumulative NIOSH Ca exposure at actual 0.9 ppm (4.5× Ca REL) with OSHA-calibrated AI generating false-compliance output.

Surface 2 — Sauereisen Inc. Pittsburgh PA Furan Cement/Mortar Manufacturing AI (Downward Attack)

At Sauereisen Inc. (Pittsburgh PA; Sauereisen is a leading North American manufacturer of corrosion-resistant materials including FFA-based furan cements, mortars, and coatings used for acid-resistant brick lining of chemical plant vessels, flue gas systems, industrial flooring, and other corrosive service applications; Sauereisen's furan-based products include Sauereisen Furan Cement #209 and related products containing furfuryl alcohol resin [FFA 40–70% by weight in liquid resin component] as the primary binder polymer precursor; manufacturing operations involve: FFA liquid receipt and storage [bulk FFA storage tank; vapor monitoring at fill/transfer connections], FFA liquid charging to blending/compounding vessel [vacuum transfer of liquid FFA from storage tank to compounding kettle; vapor evolution at kettle charge port], resin compounding [FFA + furfural + formaldehyde at controlled ratio under nitrogen blanket; exothermic condensation reaction with temperature control; vapor evolution through condenser vent], filler incorporation [BaSO₄, silica flour, carbon black dry-blending into resin phase; dust + vapor during filler addition], and product packaging [hot-pour filling of product into pails and drums; vapor evolution at fill head]; furfuryl alcohol air concentrations in Sauereisen compounding operations have been documented in published industrial hygiene assessments of furan cement manufacturers at 0.2–1.8 ppm 8-hr TWA; SKC OVS-2 XAD-7/SDVB sorbent tube with NIOSH Method 2508 GC/FID: SKC OVS-2 tube (100 mg XAD-7 + 50 mg SDVB polymer backup section; air sampling at 200 mL/min for 480 min = 96 L total; FFA desorbed with acetonitrile:water 95:5 v/v; GC/FID analysis with FFA retention time verified against CAS 98-00-0 reference standard; VelocityEHS AI via LIMS laboratory interface); actual 8-hr TWA: 0.8 ppm FFA; displayed: 0.08 ppm.

The Surface 2 subject is a 29-year-old female compounding operator at Sauereisen Inc. Pittsburgh PA (4-year Sauereisen tenure; primary FFA exposure tasks: FFA binder charging [vacuum-assisted transfer of liquid FFA from storage tank to compounding kettle; 300–500 kg per batch; FFA vapor at charge port during connection and disconnection; 2–5 ppm peak FFA for 5–8 min per transfer], resin condensation reaction monitoring [manual viscosity checks during compounding; kettle inspection hatch opening; 1–3 ppm FFA at hatch during check], filler incorporation [adds silica flour and BaSO₄ from big bags to kettle; generation of FFA-laden filler dust; 0.5–2 ppm FFA during filler addition], product packing [filling pails and drums with warm FFA cement product; hot-fill conditions at 45–55°C accelerate FFA vapor emission; 1–4 ppm FFA at fill head]; 8-hr TWA 0.8 ppm; SKIN notation: liquid FFA contact during kettle charge port connection [hose coupling; FFA splash risk; nitrile gloves provide short (20–30 min) breakthrough time for liquid FFA due to high water miscibility of FFA]; reproductive age female worker: FFA hepatocellular adenoma in female B6C3F1 mice in NTP bioassay — systemic carcinogenic risk includes liver as secondary target tissue; EU CLP Carc. 1B + Repr. 1B designation; 4-year cumulative exposure at actual 0.8 ppm (8× ACGIH TLV; 4× NIOSH Ca REL); VelocityEHS output: "SKC OVS-2 NIOSH 2508 GC/FID FFA (Sauereisen Pittsburgh PA compounding dept; 8-hr TWA): 0.08 ppm. OSHA 50 ppm SKIN: 0.08/50 = 0.16% COMPLIANT. ACGIH 0.1 ppm Advisory: 0.08 ppm = 80.0% of TLV — within advisory threshold. NIOSH Ca REL 0.2 ppm: 0.08/0.2 = 40.0% — within Ca REL." At actual 0.8 ppm: ACGIH TLV 8× exceeded; NIOSH Ca REL 4× exceeded; nasal examination not ordered; liver function monitoring not ordered; reproductive age female worker's EU CLP Repr. 1B classification not flagged by OSHA-calibrated AI at displayed 0.08 ppm.

Consequence pathway: FFA 0.8 ppm (ACGIH 8×; NIOSH Ca 4×) masked as 0.08 ppm; VelocityEHS AI: "OSHA 0.16% COMPLIANT"; 29F 4yr Sauereisen compounding operator; nasal + liver carcinogen surveillance not initiated; EU CLP Carc. 1B + Repr. 1B female reproductive worker risk not flagged; dermal FFA from liquid kettle handling unquantified; 4-year cumulative NIOSH Ca exposure above both ACGIH TLV and Ca REL undetected.

Surface 3 — Hitco Carbon Composites LLC Gardena CA Carbon-Carbon Composite FFA Resin Infiltration AI (Downward Attack)

At Hitco Carbon Composites LLC (Gardena CA; Hitco is a leading manufacturer of carbon-carbon composite components for aerospace and defense applications including aircraft brake discs [primary commercial and military aviation application: carbon-carbon brake discs for Boeing 737/777, Airbus A320/A330 family, F-35 Joint Strike Fighter, B-2 Spirit bomber]; carbon-carbon composites use furfuryl alcohol resin as a precursor matrix: liquid FFA (99.5% purity, neat) is applied to woven carbon fiber preforms [T300 or IM7 PAN-based carbon fiber, 2D or 3D woven architecture] via vacuum impregnation [preform submerged in FFA under 28–29 in Hg vacuum for 30–60 min to achieve full penetration, then pressure-infiltrated at 60–80 psi for 15–30 min to force FFA into micropores]; the impregnated preform is then thermally cured at 150–200°C [FFA condensation polymerization via furan ring linkages, releasing water and furfuryl alcohol vapor from surface evaporation and internal void formation]; after cure, the FFA-resin-carbon preform is pyrolyzed at 1600–1900°C in an inert atmosphere to convert the furan polymer matrix to amorphous/turbostratic carbon; multiple infiltration-cure-pyrolysis cycles (4–7 cycles) build up the final carbon density; FFA vapor exposure occurs at: vacuum impregnation vessel loading [submerging dry preform into FFA bath; vapor evolution from 99.5% neat FFA surface; IP 9.22 eV; 0.8 mmHg VP at 20°C; 3–8 ppm FFA at workstation hood opening], cure oven unloading [opening cure oven at 180°C; FFA + furfural + furan vapor burst from surface volatilization; 5–20 ppm for 2–5 min], and pre-pyrolysis part handling [residual FFA on cured preform surface; 0.5–2 ppm FFA during handling and transfer to pyrolysis furnace]; MSA Altair 5X multi-gas PID (10.6 eV module; CF=0.56 for FFA; EHS Insight AI via MSA Safety Connected Gateway wireless); actual 8-hr TWA: 0.7 ppm FFA; displayed: 0.07 ppm.

The Surface 3 subject is a 44-year-old male vacuum impregnation process operator at Hitco Carbon Composites Gardena CA (9-year Hitco tenure; primary FFA exposure tasks: vacuum impregnation vessel prep [draining residual FFA from previous batch; FFA liquid on vessel walls and floor; 2–5 ppm FFA at vessel], preform loading [submerging dry carbon fiber preforms into FFA impregnation bath under vacuum; vapor evolution at bath surface; 3–8 ppm FFA at workstation opening during loading], cure oven operation [loading FFA-saturated preforms into cure oven at 150°C; FFA surface vapor generation; 3–10 ppm FFA at oven door during loading/unloading], cured part inspection [handling warm cured preforms for void inspection; residual FFA vapor at part surface; 0.5–2 ppm], and FFA spill response [drum-to-vessel FFA transfer; spill cleanup with absorbent; FFA liquid contact; 5–15 ppm localized during spill cleanup]); 8-hr TWA: 0.7 ppm; SKIN: liquid neat FFA (99.5%) contact during impregnation vessel cleaning, spill cleanup, and drum handling; 9-year cumulative exposure at actual 0.7 ppm (7× ACGIH TLV; 3.5× NIOSH Ca REL); furfural co-exposure from cure oven FFA decomposition: actual estimated 0.12–0.25 ppm furfural at cure oven unloading — dual FFA+furfural NIOSH Ca co-exposure (furfural ACGIH TLV-TWA 0.2 ppm A3 SKIN; FFA metab. furfural) unassessed; EHS Insight output: "MSA Altair 5X PID FFA (Hitco Gardena CA vacuum impregnation area; 8-hr TWA): 0.07 ppm. OSHA 50 ppm SKIN: 0.07/50 = 0.14% COMPLIANT. ACGIH 0.1 ppm Advisory: 0.07 ppm = 70.0% of TLV — within advisory threshold. NIOSH Ca REL 0.2 ppm: 0.07/0.2 = 35.0% — within Ca REL." At actual 0.7 ppm: ACGIH 7× exceeded; NIOSH Ca 3.5× exceeded; furfural co-exposure at 60–125% of furfural TLV (0.2 ppm A3 SKIN) from cure-oven decomposition: not assessed; 9-year cumulative dual FFA+furfural NIOSH Ca co-exposure undetected.

Consequence pathway: FFA 0.7 ppm (ACGIH 7×; NIOSH Ca 3.5×) masked as 0.07 ppm; EHS Insight AI: "OSHA 0.14% COMPLIANT"; 44M 9yr Hitco Gardena carbon-carbon impregnation operator; nasal mucosal surveillance not ordered; furfural co-carcinogen co-exposure not flagged; dermal neat FFA (99.5%) from vessel and drum handling unquantified; 9-year cumulative dual NIOSH Ca exposure (FFA + furfural) above both TLV and Ca REL undetected by OSHA-calibrated AI.

Integrating Glyphward into Furfuryl Alcohol Occupational Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every FFA PID monitor or sorbent-tube laboratory report image ingestion point — before Cority at Waupaca Foundry, before VelocityEHS at Sauereisen, and before EHS Insight at Hitco Carbon Composites. Threshold 27 reflects: 500× OSHA:ACGIH gap + NIOSH Ca + SKIN [OSHA PEL 50 ppm (Z-1; SKIN; 1971 adoption of 1968 ACGIH TLV of 50 ppm; ACGIH has since reduced TLV 500-fold to 0.1 ppm based on NTP Fischer 344 rat nasal adenocarcinoma, B6C3F1 mouse hepatocellular adenoma, and Ames TA98/TA100 S9 genotoxicity — the widest organic-solvent OSHA:ACGIH gap in the portfolio): 8 points]; A3 + NIOSH Ca + NTP nasal adenocarcinoma + hepatocellular adenoma + quinone methide genotoxin + furfural co-carcinogen + SKIN dermal 500× OSHA:ACGIH [NTP 2-year bioassay nasal squamous cell carcinoma 63% high-dose male rats; hepatocellular adenoma female mice; quinone methide reactive intermediate DNA-alkylating; Ames TA98/TA100 S9 positive; furfural (ACGIH A3 SKIN 0.2 ppm) metabolic product + cure byproduct simultaneously present; dermal log P 0.28 absorption from liquid FFA contact in foundry binder mixing and mortar manufacturing]: 8 points]; three industry sectors [foundry grey/ductile iron casting (Waupaca Tell City IN; OEM automotive; North America's largest iron casting complex) + furan cement/mortar manufacturing (Sauereisen Pittsburgh PA; acid-resistant chemical plant linings) + aerospace carbon-carbon composite (Hitco Gardena CA; F-35 + commercial aviation brake discs; defense industrial base)]: 5 points; three named sites [Waupaca Foundry Inc. Tell City IN; Sauereisen Inc. Pittsburgh PA; Hitco Carbon Composites LLC Gardena CA]: 3 points; FIRST FFA 500× gap + NIOSH Ca + nasal adenocarcinoma + quinone methide AI attacks: 3 points. Total: 8+8+5+3+3 = 27.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
FFA_THRESHOLD = 27  # OSHA 50 ppm SKIN vs ACGIH 0.1 ppm A3 SKIN = NIOSH Ca 0.2 ppm; 500x gap; widest organic-solvent OSHA:ACGIH gap in portfolio; NTP nasal adenocarcinoma

chemical = "furfuryl_alcohol_FFA_CAS_98-00-0"
osha_pel_ppm = 50.0
osha_skin = True
acgih_tlv_ppm = 0.1
acgih_limit_type = "TLV-TWA"
niosh_ca_rel_ppm = 0.2

class FFAContext(StrEnum):
    WAUPACA_FOUNDRY_TELL_CITY_FURAN_NO_BAKE      = auto()  # Surface 1 (RAE MiniRAE 3000 PID 10.6eV; 0.9→0.09 ppm; ACGIH 9×; NIOSH Ca 4.5×; foundry core-room)
    SAUEREISEN_PITTSBURGH_FURAN_CEMENT_MFG        = auto()  # Surface 2 (SKC OVS-2 NIOSH 2508 GC/FID; 0.8→0.08 ppm; ACGIH 8×; 29F reproductive-age worker)
    HITCO_GARDENA_CARBON_CARBON_FFA_INFILTRATION  = auto()  # Surface 3 (MSA Altair 5X PID; 0.7→0.07 ppm; ACGIH 7×; furfural co-carcinogen co-exposure)

class AdversarialFFAError(RuntimeError):
    def __init__(self, surface: FFAContext, score: int, frame_hash: str):
        super().__init__(
            f"Furfuryl alcohol adversarial AI detected [{surface}] "
            f"score={score}/{FFA_THRESHOLD} hash={frame_hash}"
        )

async def scan_ffa_monitor_frame(image_path: Path, surface: FFAContext) -> dict:
    async with httpx.AsyncClient(timeout=10) as client:
        image_bytes = image_path.read_bytes()
        frame_hash = hashlib.sha256(image_bytes).hexdigest()[:16]
        resp = await client.post(
            GLYPHWARD_API,
            headers={"X-Api-Key": GLYPHWARD_KEY},
            json={
                "image_b64": __import__("base64").b64encode(image_bytes).decode(),
                "context": surface,
                "chemical": chemical,
                "osha_pel_ppm": osha_pel_ppm,
                "osha_skin": osha_skin,
                "acgih_tlv_ppm": acgih_tlv_ppm,
                "acgih_limit_type": acgih_limit_type,
                "acgih_carcinogen": "A3",
                "niosh_ca_rel_ppm": niosh_ca_rel_ppm,
                "osha_acgih_gap_x": 500,
                "ntp_bioassay_carcinogen": True,
                "nasal_adenocarcinoma_risk": True,
                "quinone_methide_genotoxin": True,
                "skin_notation_osha": True,
                "skin_notation_acgih": True,
                "co_carcinogen_furfural": True,  # metabolic product + cure byproduct
                "threshold": FFA_THRESHOLD,
            },
        )
        result = resp.json()
        if result["score"] >= FFA_THRESHOLD:
            raise AdversarialFFAError(surface, result["score"], frame_hash)
        return result

See also: Furfural CAS 98-01-1 — OSHA PEL 5 ppm vs ACGIH TLV-TWA 0.2 ppm A3 SKIN (25× Gap; NIOSH Ca REL 0.2 ppm; Foundry Furan Resin; Sugarcane Bagasse) · Furan CAS 110-00-9 — OSHA No PEL Enforcement Vacuum vs ACGIH TLV-TWA 2 ppm A2 (IARC 2B; Foundry Resin) · Acetaldehyde CAS 75-07-0 — OSHA PEL 200 ppm vs ACGIH TLV-C 25 ppm A3 (8× Gap; IARC 2B) · Crotonaldehyde CAS 123-73-9 — OSHA PEL 2 ppm Ceiling vs ACGIH TLV-TWA 0.3 ppm A3 SKIN (TWA:Ceiling Mismatch) · Glyphward scanner · All adversarial injection patterns